The role of Coxsackie Group B virus infections in sporadic myopericarditis

1971 ◽  
Vol 82 (6) ◽  
pp. 750-758 ◽  
Author(s):  
Clyde H. Koontz ◽  
C.George Ray
1963 ◽  
Vol 13 (1-3) ◽  
pp. 160-166 ◽  
Author(s):  
E. Irene Grodums ◽  
G. Dempster ◽  
W. A. Spencer

1974 ◽  
Vol 73 (2) ◽  
pp. 165-172 ◽  
Author(s):  
N. R. Grist ◽  
Eleanor J. Bell

SUMMARYVirological examination of 385 patients with suspected heart disease and 26 with Bornholmdisease over a period of 6 years suggested that Coxsackie group B virus infections were associated with at least half the cases of acute myocarditis and one third of the cases ofacute non-bacterial pericarditis. Complement-fixation tests revealed only a few cardiac illnesses associated with other infections (influenza and Mycoplasma pneumoniae). No evidence of infection was found in chronic cardiac disease.


1984 ◽  
Vol 93 (2) ◽  
pp. 197-203 ◽  
Author(s):  
Eleanor J. Bell ◽  
Robert A. McCartney

SummaryThe results of a twelve-year study of Coxsackie B virus (CBV) infections in patients with a variety of acute and chronic illnesses are reported. CBVs were isolated from only 123 patients most of whom were children with respiratory illness. Virus diagnosis in adults was based mainly on the detection of significant rising or static high neutralizing antibody titrcs. Between 1972 and 1979 most investigations centred on patients with suspected viral heart disease, 12% of whom were found to have diagnostically significant CBV titres. In studies on patients with definite myo-pericarditis the number positive increased to 33%. In 1980 clinical interest switched to the possible role of CBV in myalgic encephalomyelitis (ME), an illness of diverse symptomatology. Investigation of suspected cases of ME in 1983 showed that 16% were serologically positive compared to 4% of normal adults in the West of Scotland. In patients with well-documented ME this figure rose to 41%.The demand by clinicians for CBV neutralizing antibody tests has increased over the past twelve years and continues to escalate annually, especially in patients with chronic relapsing illness.


1961 ◽  
Vol 7 (4) ◽  
pp. 587-594 ◽  
Author(s):  
George Dempster ◽  
E. Irene Grodums ◽  
W. A. Spencer

It has been shown for the first time that Coxsackie B-3 virus will infect hibernating mammals such as the ground squirrel and the bat, in both the hibernating and nonhibernating states. Pathological changes in the heart and brown fat of squirrels in hibernation were comparable with those observed in mice. In squirrels the brain appeared to be relatively resistant, although the region of the olfactory bulb was often involved. Although no lesions were observed in bats killed in hibernation, a few died with meningoencephalitis. Viraemia was observed in both species and found to be more persistent in the bat.Biochemical studies were conducted upon the normal brown fat of the different species, and it was interesting to find that whereas the morphology and lipid content (total lipid and phospholipid) of the young mouse, adult squirrel, and adult bat were very similar, the corresponding characters of adult mouse brown fat showed marked differences. The significance of the resemblance of young mouse brown fat to that found in the hibernating mammal is being assessed further in the light of the function of the brown fat and its susceptibility to Coxsackie group B virus infection.


1974 ◽  
Vol 88 (3) ◽  
pp. 311-314 ◽  
Author(s):  
Prapit Sudhas Na Ayuthya ◽  
Jidbhong Jayavasu ◽  
Boonchob Pongpanich

Sign in / Sign up

Export Citation Format

Share Document